lifenews.com
2025-05-03
One in ten patients experience a "serious adverse event" after taking the abortion pill, according to a study released Monday by the Ethics and Public Policy Center (EPPC), a conservative think tank and advocacy group.
The study found that 10.93% of women experienced sepsis, infection, hemorrhaging, or another serious adverse event within 45 days after a mifepristone abortion. The real-world rate of serious adverse events after mifepristone abortions is at least 22 times as high as the summary figure of "less than 0.5%" in clinical trials reported on the drug label, according to the study.
Mifepristone, when used together with another medication called misoprostol, is used to have an abortion during the first ten weeks of pregnancy, according to the U.S. Food and Drug Administration (FDA). Danco Laboratories, a pharmaceutical distributor based in Manhattan, distributes mifepristone under the brand name Mifeprex, and claims on their website that the drug is "safe and effective."
Experts Urge Trump to Stop Abortion Pill After Study Shows Huge Complication Rates by S.A. McCarthy